Agape ATP Corp
Nasdaq · CIK 0001713210 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$273,658
Cost Of Revenue
$114,249
Gross Profit
$159,409
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $273,658 | - | - |
| Cost Of Revenue | $114,249 | - | - |
| Gross Profit | $159,409 | - | - |
| Operating Income | $-677,372 | - | - |
| Net Income | $-340,906 | - | - |
| Eps Basic | -0.33 | - | - |
| Eps Diluted | -0.33 | - | - |
| Cash And Equivalents | $220,779 | - | - |
| Total Assets | $24.9M | - | - |
| Total Liabilities | $2.8M | - | - |
| Shareholders Equity | $22.1M | - | - |
| Operating Cash Flow | $-394,770 | - | - |
| Capital Expenditures | $649 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Agape ATP Corp | 2026-05-15 | 0001493152-26-023388 |
| 10-K | Agape ATP Corp | 2026-04-13 | 0001493152-26-016297 |
| 10-Q | Agape ATP Corp | 2025-11-13 | 0001493152-25-022092 |
| 10-Q | Agape ATP Corp | 2025-08-13 | 0001641172-25-023358 |